Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Intellikine, Chasing Hot Cancer Drug Target, Raises Big Venture Round
|
Luke Timmerman |
07/02/09 |
San Diego
|
|
Stem Cell Entrepreneur Quinn Dies, Dendreon Tames Shorts, PhysioSonics Monitors Brain Blood, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/02/09 |
Seattle
|
|
Illumina Sales Miss Expectations
|
Luke Timmerman |
07/01/09 |
San Diego
|
|
CombinatoRx to Combine with Neuromed, CEO Borisy Steps Down
|
Ryan McBride |
07/01/09 |
Boston
|
|
New England Firms Poised for Biogeneric Future, Tobin Bids Boston Scientific Adieu, Biogen Idec Reports Tenth PML Case, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/01/09 |
Boston
|
|
Amag Pharmaceuticals Wins FDA Approval to Sell Iron Deficiency Drug
|
Luke Timmerman |
06/30/09 |
Boston
|
|
Stephen Quinn, Biotech and Medical Device Entrepreneur, Dies Suddenly at 46
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
CTI, OncoGenex Join Russell Indexes
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
Dendreon Tames Short Sellers, Transforms Itself into Old-School Buy-and-Hold Stock
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
Biotech Gaining Ground in Washington State, Report Says
|
Eric Hal Schwartz |
06/30/09 |
Seattle
|
|
Biogen Reports 10th PML Case in Tysabri Patient
|
Roxanne Palmer |
06/29/09 |
Boston
|
|
Xconomy, San Diego Union-Tribune Enter Into Syndication Partnership
|
Bruce V. Bigelow |
06/29/09 |
San Diego
|
|
Aveo Pieces Together a Plan to Rival Big Boys of Cancer Drug World
|
Luke Timmerman |
06/29/09 |
Boston
|
|
PhysioSonics, Looking at Blood in the Brain, Aims to Monitor Effects of Drugs
|
Luke Timmerman |
06/29/09 |
Seattle
|
|
PhysioSonics Nabs $2M
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Boston Scientific CEO Retires, Replaced by Former Zimmer Boss
|
Luke Timmerman |
06/25/09 |
Boston
|
|
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Cell Therapeutics Files Cancer Drug Application, In Nick of Time
|
Luke Timmerman |
06/24/09 |
Seattle
|
|
Amnis Rolls Out Souped Up Scientific Tool, Just as Customers Start Feeling Flush
|
Luke Timmerman |
06/24/09 |
Seattle
|
|
Life Science Leaders Converge in Newport, PubGet Gets Your Paper Faster, I-Therapeutix Eyes $15M Prize & More Boston-Area Life Sciences News
|
Roxanne Palmer |
06/24/09 |
Boston
|
|
One Day Til XSITE: Just A Few Seats Left, but Plenty of Innovation to Go Around
|
Editors |
06/23/09 |
Boston
|
|
Amazon Buys SnapTell, Madrona Backs Animoto, MDRNA Works Out Tech License, & More Seattle-Area Deals News
|
Gregory T. Huang |
06/23/09 |
Seattle
|
|
Oncothyreon Drug Enters Pivotal Trial
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
AVI Developing Swine Flu Drugs
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Targeted Genetics Cuts Workforce in Half in Bid to Survive Into August
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Mirabilis Medica Aims to Help Women Avoid the Dreaded Hysterectomy
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Cell Therapeutics Dumps $52.9M Debt
|
Luke Timmerman |
06/19/09 |
Seattle
|
|
Innovation Insights, and How Microsoft Enabled the Internet, From Technologist Dan Rosen
|
Gregory T. Huang |
06/19/09 |
Seattle
|
|
Sorrento Therapeutics Raises $2.3 Million
|
Bruce V. Bigelow |
06/19/09 |
San Diego
|
|
MDRNA Gains Full Rights to Drug Technology
|
Luke Timmerman |
06/19/09 |
Seattle
|
|
Page 1 of
54 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
